PRESS RELEASES
September 22, 2025
(title to be announced soon)
September 22, 2025
Despite advances in hypertension treatment, nearly 75% of U.S. adults still struggle with uncontrolled blood pressure. A new nationwide analysis highlights the vast potential – and risks – of renal denervation (RDN) as a therapeutic option.
September 22, 2025
Renal denervation is gaining traction as a powerful tool in hypertension management—but it's not for everyone. Discover how ESC and ESH guidelines, clinical evidence, and practical tools like the Recor Medical selection form help identify the right candidates.
September 22, 2025
Managing hypertension with renal denervation: all you need to know for your patients
September 22, 2025
A Joint Interview with Prof. Konstantinos Tsioufis (University of Athens, Hippocratio Hospital, Greece) and Prof. Sofie Brouwers (OLV Ziekenhuis Aalst, Belgium).
September 22, 2025
A new clinical trial reveals that something as simple as arm position can skew blood pressure readings by up to 6.5 mm Hg — enough to misdiagnose hypertension or trigger unnecessary treatment. Find out what the study uncovered and why proper technique matters more than ever.
September 1, 2025
First Medical Device Approved in Japan for the Treatment of Hypertension.
September 1, 2025
Recor Medical and Otsuka Medical Devices welcome the recognition of renal denervation as a therapy option for resistant or uncontrolled hypertension in the 2025 AHA/ACC Guidelines.
